COVID-19: Get tested for COVID-19, learn about vaccine eligibility and scheduling, and view current visitor precautions at our health care locations.

Our mission is to improve the lives of individuals living with traumatic injuries to the spinal cord or brain through collaborative innovation in research, rehabilitation and clinical care.

We are committed to developing better treatments for brain and spinal cord injuries. We value a multidisciplinary and interactive culture dedicated to our common goals:

To improve understanding of the biological mechanisms underlying neurodegeneration and endogenous repair of the central nervous system
To identify novel targets and promising clinical therapies for individuals with brain and spinal cord injuries
To develop and improve rehabilitation strategies to maximize recovery and quality of life
To improve personalized care through identification of biomarkers for differentiation and diagnosis of neurological disorders and their effective treatment
The CBSCR is not a patient care facility. We are primarily a pre-clinical research center that strives for novel discoveries that will improve the lives of people who suffer a traumatic brain or spinal cord injury.

CBSCR Research Teams are working together to improve our understanding of the biology of brain and spinal cord injury and to develop new and effective treatments to promote recovery and improve quality of life.

Through cutting-edge research, our faculty and staff are advancing the field of neurotrauma in three key areas:

Neuroprotection
Neuroregeneration and Plasticity
Neurorehabilitation

Our Team

At the Center for Brain and Spinal Cord Repair, our multidisciplinary team collaborates to translate discoveries into life-changing treatments.

Learn more

Stories

Chronic complications from spinal cord injury studied

Research shows spinal cord ability to replace myelin lost to injury

Current Projects

Acute Traumatic SCI Study

More than a quarter million Americans live with spinal cord injuries, which result in variable sensory and motor paralysis. Health care costs for these patients exceed $3 billion per year, in addition to significant physical, psychological and social costs.

The Department of Neurological Surgery at Ohio State University Wexner Medical is actively screening patients in a clinical trial for a new investigational treatment that is hypothesized to safely and effectively improve motor function following acute traumatic cervical spinal cord injury. The drug, a compound known as VX-210 (Vertex Pharmaceuticals), is applied directly on the injured spinal cord and could potentially block a molecule that plays a major role in preventing nerve regeneration.

Participants must be between 14 and 75 years of age and scheduled to undergo a spinal decompression/stabilization surgery within 72 hours of the initial injury. Subjects will be randomized into three groups: two will receive the compound at different doses and another will receive a placebo. At least four follow-up evaluations within 12 months will be undertaken for all participants.

Ohio State Wexner Medical Center is currently the only hospital in Ohio enrolling for this study.

For additional information and enrollment criteria for the VX-210 study at OSUWMC, contact Francis Farhadi at 614-366-4961 or visit clinicaltrials.gov.
NIH Sponsored Spinal Cord Injury Training Program

Our Location

695 Biomedical Research Tower
460 West 12th Avenue
Columbus, OH 43210
Phone: 614-688-8576
Fax: 614-688-5463

Share this Page

Live healthier and stay inspired.

Get tips from Ohio State experts right to your inbox.

Email address

First name

Last name

Date of birth

ZIP code

Gender

By clicking "Subscribe" you agree to our Terms of Use.

Thank you! Look for your first email in your inbox soon.

We'll be in touch every so often with health tips, patient stories, important resources and other information you need to keep you and your family healthy. Welcome to our online community here at the Ohio State Wexner Medical Center!